Aberrant claudin-4 transcript levels in eutopic endometrium of women with idiopathic infertility and minimal endometriosis

Ginekologia Polska

Volumn 84, Issue 2, 2013, Pages 90-94

  Mateusz, Mikołajczyk ^a   Przemysław, Wirstlein ^a   Jana, Skrzypczak ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Claudin; Endometriosis; Endometrium; Idiopathic infertility

Indexed keywords

EID: 84875509022     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Modi D, Godbole G, Suman P, Gupta S. Endometrial biology during trophoblast invasion. Front Biosci (Schol Ed). 2012, 1, 1151-1171.
2. Najafi T, Novin M, Ghazi RKhorram O. Altered endometrial expression of endothelial nitric oxide synthase in women with unexplained recurrent miscarriage and infertility. Reprod Biomed Online. 2012, 25, 408-414.
3. Furuya M, Ishida J, Aoki I, Akiyoshi F. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension. Vasc Health Risk Manag. 2008, 4, 1301-1313.
4. Tersigni C, Marana R, Santamaria A, [et al.]. In vitro evidences of heparin's effects on embryo implantation and trophoblast development. Reprod Sci. 2012, 5, 454-462.
5. Ray A, Shah A, Gudi A, Homburg. Unexplained infertility: an update and review of practice. Reprod Biomed Online. 2012, 6, 591-602.
6. Check J. The association of minimal and mild endometriosis without adhesions and infertility with therapeutic strategies. Clin Exp Obstet Gynecol. 2003, 30, 35-39.
7. Cruz M, Garrido N, Herrero J, [et al.]. Timing of cell division in human cleavage-stage embryos is linked with blastocyst formation and quality. Reprod Biomed Online. 2012, 25, 371-381.
8. Minas V, Loutradis D, Makrigiannakis A. Factors controlling blastocyst implantation. Reprod Biomed Online. 2005, 2, 205-216.
9. Kao L, Tulac S, Lobo S, [et al.]. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 2002, 143, 2119-2138.
10. Riesewijk A, Martin J, van Os R, [et al.]. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod. 2003, 9, 253-264.
11. Giudice L. Elucidating endometrial function in the post-genomic era. Hum Reprod Update. 2003, 9, 223-235.
12. Tsukita S, Furuse M. Pores in the wall: claudins constitute tight junctionstrands containing aqueous pores. J Cell Biol. 2000, 149, 13-16.
13. Carson D, Largow E, Thathiah A, [et al.]. Changes in gene expression during early to mid luteal (receptive phase) transition in human endometrium detected\by high density microarray screening. Mol Human Reprod. 2002, 8, 871-879.
14. Katahira J, Sugiyama H, Inoue N, [et al.]. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem. 1997, 17, 26652-26658.
15. Blanchard A, Watson P, Shiu R, [et al.]. Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse. DNA Cell Biol. 2006, 25, 79-86.
16. Kominsky S, Vali M, Korz D, [et al.]. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol. 2004, 164, 1627-1633.
17. Nichols L, Ashfaq R, Iacobuzio-Donahue C. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol. 2004, 121, 226-230.
18. Sheehan G, Kallakury B, Sheehan C, [et al.]. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol. 2007, 38, 564-569.
19. Santin A, Zhan F, Cane' S, [et al.]. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. Br J Cancer. 2005, 92, 1561-1573.
20. Santin A, Bellone S, Marizzoni M, [et al.]. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE). Cancer. 2007, 109, 1312-1322.
21. Zhu Y, Brannstrom M, Janson P, Sundfeldt K. Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer. 2006, 118, 1884-1891.
22. Rangel L, Agarwal R, D'Souza T, [et al.]. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res. 2003, 9, 2567-2575.
23. Pan X, Wang B, Che Y, [et al.]. Expression of claudin-3 and claudin-4 in normal, hyperplastic and malignant endometrial tissue. Int J Gynecol Cancer. 2007, 17, 233-241.
24. Pan X, Li X, Weng Z, Wang B. Altered expression of claudin-3 and claudin-4 in ectopic endometrium of women with endometriosis. Fertil Steril. 2009, 91, 1692-1699.
25. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine Revised classification of endometriosis: 1996. Fertil Steril. 1997, 67, 817-821.
26. Spanddorfer S, Avrech O, Colombero L, [et al.]. Effect of parental age on fertilization and pregnancy characteristics in couples treated by intracytoplasmic sperm injection. Hum Reprod. 1998, 13, 334-338.
27. Friedler S, Gilboa S, Schachter M, [et al.]. Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study. RBM Online. 2006, 12, 27-32.
28. Albano C, Smitz J, Tournaye H, [et al.]. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in invitro fertilization/intracytoplasmic sperm injection cycles. Human Reprod. 1999, 14, 1426-1430.
29. Polish Gynecological Society and Polish Society for Reproductive Medicine. Polish Gynecological Society and Polish Society for Reproductive Medicine recommendations for the diagnosis and treatment of infertility. Ginekol Pol. 2012, 83, 149-154.
30. Liu J, Sills E, Yang Z, [et al.]. Array comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservation. Clin Exp Reprod Med. 2012, 39, 52-57.
31. Sermondade N, Delarouziere V, Ravel C, [et al.]. Characterization of a recurrent poor-quality embryo morphology phenotype and zygote transfer as a rescue strategy. Reprod Biomed Online. 2012, 24, 403-409.
32. Harper J, Sengupta S. Preimplantation genetic diagnosis: state of the art 2011. Hum Genet. 2012, 131, 175-186.
33. Ferraretti A, Goossens V, de Mouzon J, [et al.]. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod. 2012, 27, 2571-2584.
34. Koch J, Rowan K, Rombauts L, [et al.]. Endometriosis and Infertility - a consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence). Aust N Z J Obstet Gynaecol. 2012, 52, 513-522.
35. Homburg R. The case for initial treatment with intrauterine insemination as opposed to in vitro fertilization for idiopathic infertility. Hum Fertil (Camb). 2003, 6, 122-124.
36. Zeitoun K, Bulun S. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril. 1999, 72, 961-969.
37. Szczepańska M, Wirstlein P, Skrzypczak J, Jagodziński P. Expression of HOXA11 in the mid-luteal endometrium from women with endometriosis-associated infertility. Reprod Biol Endocrinol. 2012, Jan 10, 10, 1.
38. Sharpe-Timms K. Endometrial anomalies in women with endometriosis. Ann N YAcad Sci. 2001, 943, 131-147.
39. Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig. 2006, 13, 467-476.
40. Bharti S, Handrow-Metzmacher H, Zickenheiner S, [et al]. Novel membrane protein shrew-1 targets to cadherin-mediated junctions in polarized epithelial cells. Mol Biol Cell. 2004, 15, 397-406.
41. Fujimoto J, Ichigo S, Hori M, Tamaya T. Expression of E-cadherin, alpha- and beta-catenin mRNAs in ovarian endometriosis. Eur J ObstetGynecol Reprod Biol. 1996, 67, 179-183.
42. Serafini P, Silva I, Smith G, [et al.]. Endometrial claudin-4 and leukemia inhibitory factor are associated with assisted reproduction outcome. Reprod Biol Endocrinol. 2009, 19, 7-30.
43. Serafini P, Da Rocha A, De Toledo Osório C, [et al.]. Protein profile of the luteal phase endometrium by tissue microarray assessment. Gynecol Endocrinol. 2009, 25, 587-592.